PO.PR02.02 · 预防研究

阐明RELT与Filamin A之间的分子相互作用及该相互作用在乳腺癌细胞中的生理学作用

Elucidating the molecular interaction between RELT and Filamin A and the physiological role of this interaction in breast cancer cells

编号 7635 展板 22 时间 4/22 09:00–12:00 区域 Section 36 主讲 Samantha Wong, BS
分会场 Cancer and Cancer Related Alterations, Detection Approaches, and Molecular Characterization
该海报暂无可下载的资料 AACR 官方页面

作者与单位 Authors & Affiliations

Samantha Wong1, Ashley Ko1, Yashar Pourmoghadam1, Hunter Hudgins1, Maryann Batiste1, Bethany Joy1, Ashley Christensen1, Eslam Mohamed2, John K. Cusick3

1College of Medicine, California Northstate University, Elk Grove, CA,2California Northstate University, Elk Grove, CA,3Department of Medical Education, University of California, Merced, Merced, CA

摘要 Abstract

中文摘要
淋巴组织表达受体(RELT)是肿瘤坏死因子受体超家族的成员,此前已证实其在乳腺癌中上调。一项蛋白质组学筛选将Filamin A(FLNA)——一种参与包括DNA修复、信号转导和细胞迁移在内多种细胞过程的肌动蛋白结合支架蛋白——鉴定为潜在的RELT相互作用伙伴。FLNA被认为在乳腺癌中发挥重要作用,因为其表达与肿瘤分级和分期相关,并且已证实其能同时结合BRCA1和BRCA2。本研究旨在进一步探索RELT与FLNA之间的这一新型相互作用,并阐明其生理学意义。 采用酵母双杂交筛选鉴定出FLNA的一个羧基末端片段(C-FLNA)为潜在的RELT结合伙伴。在HEK-293细胞中瞬时过表达C-FLNA及RELT的缺失突变体,随后进行共免疫沉淀(co-IP)和蛋白质印迹分析,以确定RELT上与FLNA结合的位点。采用免疫荧光(IF)显微镜评估RELT-FLNA在MDA-MB-231(231)乳腺癌细胞中的亚细胞共定位。为考察C-FLNA对RELT诱导细胞死亡能力的影响,将作为三阴性乳腺癌模型的231细胞用RELT、FLNA突变体和空载体对照质粒的不同组合进行瞬时转染。随后,采用Annexin V/碘化丙啶(AV/PI)染色,通过流式细胞术分析这些细胞的凋亡情况。 采用缺失突变体进行的co-IP实验证明,C-FLNA结合于RELT胞内结构域第340-400位氨基酸之间。IF研究证实了RELT与FLNA的胞质共定位,支持这两种蛋白之间存在直接相互作用。流式细胞术数据显示,与单独表达任一蛋白的细胞相比,RELT与C-FLNA共表达在231细胞中诱导出显著更高的AV/PI染色,表明凋亡水平更高。 这些发现界定了RELT上供FLNA结合的胞内结合区域。此外,RELT与C-FLNA共表达导致乳腺癌细胞凋亡显著增强,提示存在潜在的协同效应。鉴于FLNA在细胞骨架动力学和运动性中已确立的作用,当前研究正在考察RELT表达是否影响乳腺癌细胞迁移。总之,这些结果增进了我们对RELT(一种在乳腺癌中上调的蛋白)与FLNA(一种对乳腺癌的重要性已被充分确立的蛋白)之间相互作用的理解。
查看英文原文 English abstract
Receptor Expressed in Lymphoid Tissues (RELT) is a member of the Tumor Necrosis Factor Receptor Superfamily that was previously shown to be upregulated in breast cancer. A proteomic screen identified Filamin A (FLNA), an actin-binding scaffold protein involved in various cell processes, including DNA repair, signal transduction, and cell migration, as a potential RELT-interacting partner. FLNA is implicated to play a vital role in breast cancer, as its expression correlates with tumor grade and stage, and it has been shown to bind both BRCA1 and BRCA2. This study aimed to further explore the novel interaction between RELT and FLNA and to characterize its physiological significance. A yeast two-hybrid screen was utilized to identify a carboxy-terminal fragment of FLNA (C-FLNA) as a potential RELT-binding partner. Transient overexpression of C-FLNA and deletion mutants of RELT in HEK-293 cells, followed by co-immunoprecipitation (co-IP) and western blotting, was performed to identify the binding site on RELT for FLNA. Immunofluorescence (IF) microscopy was used to evaluate RELT-FLNA subcellular colocalization in MDA-MB-231 (231) breast cancer cells. To examine the impact of C-FLNA on RELT's ability to induce cell death, 231 cells, a model for triple-negative breast cancer, were transiently transfected with varying combinations of RELT, FLNA mutants, and empty vector control plasmids. Consequently, these cells were analyzed for apoptosis via flow cytometry, using Annexin V/Propidium Iodide (AV/PI) staining. Co-IP experiments performed with deletion mutants demonstrated that C-FLNA binds within amino acids 340-400 of RELT's intracellular domain. IF studies confirmed cytosolic colocalization of RELT and FLNA, supporting a direct interaction between these two proteins. Flow cytometry data revealed that co-expression of RELT and C-FLNA induced significantly higher AV/PI staining in 231 cells, indicating greater levels of apoptosis, compared to cells expressing either protein alone. These findings define an intracellular binding region on RELT for FLNA binding. Furthermore, co-expression of RELT and C-FLNA resulted in significantly enhanced apoptosis in breast cancer cells, suggesting a potentially synergistic effect. Current studies are examining whether RELT expression influences breast cancer cell migration given FLNA's established role in cytoskeletal dynamics and motility. Collectively, these results enhance our understanding of the interaction between RELT, a protein that is upregulated in breast cancer, and FLNA, a protein whose importance for breast cancer has been well established.
利益披露 Disclosure
S. Wong, None.. A. Ko, None.. Y. Pourmoghadam, None.. H. Hudgins, None.. M. Batiste, None.. B. Joy, None.. A. Christensen, None.. E. Mohamed, None.. J. K. Cusick, None.

← 返回 AACR 2026 检索